Enzyme Immunoassay (EIA) Reagents and Kits Market Research Identifies Key Trends in Infectious Disease Diagnostics and Immunoassay Technology

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Enzyme Immunoassay (EIA) Reagents And Kits Market- by Product Type (Reagents and Kits), Technology (ELISA, Indirect ELISA, Sandwich ELISA, and Multiple/Portable ELISA), Application (Infectious Diseases, Cardiology, Oncology, Bone and Mineral, Autoimmunity, Endocrinology, Toxicology, Neonatal Screening, Hematology, and Others), End-User (Hospital Laboratories, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Academics and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the global Enzyme Immunoassay (EIA) Reagents And Kits market is valued at 19.80 Billion in 2022, and it is expected to reach 31.60 Billion by the year 2031, with a CAGR of 5.5 % during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1059

Enzyme immunoassay (EIA) reagents and equipment are essential diagnostic tools used to detect the presence or quantify the concentration of antigens associated with epidemiological diseases. These assays utilize various enzymes, such as glucose oxidase and alkaline phosphatase, and are categorized based on their technological capabilities. They have broad applications across multiple medical domains, including oncology, toxicology, endocrinology, autoimmunity, hematology, and neonatal screening.

The global market for EIA reagents and equipment is experiencing robust growth, driven by the increasing prevalence of chronic and infectious diseases, as well as a growing aging population. Chronic conditions such as diabetes, cardiovascular diseases, and cancer are on the rise globally, while infectious diseases-including SARS-CoV-2 (COVID-19), HIV, malaria, tuberculosis, dengue, and hepatitis B and C-continue to pose significant public health challenges. Immunoassays have become a fundamental component of disease diagnostics, supported by ongoing advancements in immunoassay technologies that offer improved sensitivity, faster turnaround times, enhanced detection limits, and greater cost-efficiency.

Market demand is further supported by increased research and development activities in the pharmaceutical sector aimed at the discovery of novel therapeutics and healthcare innovations. Additionally, the continued expansion of biotechnological and biopharmaceutical companies contributes to the market's upward trajectory.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Geographically, North America is projected to lead the enzyme immunoassay reagents and equipment market during the forecast period. This dominance is attributed to strong government support for research initiatives, increased development of novel drugs and disease biomarkers, and a mature healthcare infrastructure. Meanwhile, the Asia Pacific region is expected to exhibit significant market growth due to rising public and private investments in EIA technologies, coupled with a growing burden of chronic and infectious diseases. These regional dynamics collectively highlight the expanding role of enzyme immunoassay reagents and equipment in the global diagnostics landscape.

Major market players operating in the Enzyme Immunoassay (EIA) Reagents And Kits market include
Affymetrix, Inc., American Laboratory Products Company, Thermo Fisher Scientific. Inc., BioMérieux SA, Beckman Coulter Inc., QIAGEN, Quidel, Ortho-Clinical Diagnostics, Inc., R&D Systems Inc., BD Biosciences, Life Technologies Corporation, ZEUS Scientific, Inc. and Other Prominent Players.

Recent collaborations and agreements in the market:
• In February 2021, Mesa Biotech, a private point-of-care molecular diagnostic company, was bought by Thermo Fisher Scientific Inc. Starting with COVID-19 testing, Mesa Biotech is a key component of the company's plan to increase the advantages of molecular diagnostics at the point of care.
• In January 2021, Abbott approved CE Mark for their Panbio COVID-19 Ag Rapid Test Device for asymptomatic SARS-CoV-2 viral diagnosis. It also has self-swabbing capabilities.
• In October 2020, for the detection of COVID-19 antibodies, Thermo Fisher Scientific introduced the EliA SARS-CoV-2-Sp1 IgG test and the OmniPATH COVID-19 Total Antibody ELISA test.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1059

Market Segments
Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Technology, 2022-2030 (Value US$ Mn)
• Competitive ELISA
• Indirect ELISA
• Sandwich ELISA
• Multiple/portable ELISA
Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Product Type, 2022-2030 (Value US$ Mn)
• Reagents
• Kits
Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Application, 2022-2030 (Value US$ Mn)
• Infectious Diseases
• Cardiology
• Oncology
• Bone and Mineral
• Autoimmunity
• Endocrinology
• Toxicology
• Neonatal screening
• Hematology
• Others
Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by End-Users, 2022-2030 (Value US$ Mn)
• Hospital Laboratories
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Reference Laboratories
• Academics
• Others
Global Enzyme Immunoassay (EIA) Reagents And Kits Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Enzyme Immunoassay (EIA) Reagents And Kits Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Enzyme Immunoassay (EIA) Reagents And Kits market
 To receive an industry overview and future trends of the Enzyme Immunoassay (EIA) Reagents And Kits market
 To analyze the Enzyme Immunoassay (EIA) Reagents And Kits market drivers and challenges
 To get information on the Enzyme Immunoassay (EIA) Reagents And Kits market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Enzyme Immunoassay (EIA) Reagents And Kits market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-enzyme-immunoassay-eia-reagents-and-kits-market/1059

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.